Accord Healthcare, Inc., the US subsidiary of Intas Pharmaceuticals, is a leading generic pharmaceutical company headquartered in Durham, North Carolina. Through its subsidiaries, Intas markets its products in 80 countries.
Founded in 1977, one of the top international firms for the creation, production, and marketing of pharmaceutical formulations is Intas Pharmaceuticals. It is the largest privately held Indian generic pharma firm and is now rated ninth in the Indian pharmaceutical industry.
Pharmabiz: Kashiv BioSciences and Intas Pharma ink exclusive licensing and supply agreement for complex peptide product in Europe, UK & India
Kashiv BioSciences and Intas Pharma ink exclusive licensing and supply agreement for complex peptide product in Europe, UK & India
MSN: Kashiv BioSciences and Intas Pharmaceuticals sign an exclusive licensing and supply agreement for complex peptide product in Europe, the UK and India
Kashiv BioSciences and Intas Pharmaceuticals sign an exclusive licensing and supply agreement for complex peptide product in Europe, the UK and India
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at ~22% CAGR.
London -headquartered Accord Healthcare is a fully owned subsidiary of Intas Pharmaceuticals, which deals with large-scale generic pharmaceuticals across Europe and North America markets. It also manages an American R&D unit which is located at Research Triangle Park, Durham.
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5...